FIELD: pharmaceutical industry. SUBSTANCE: invention proposes utilization of melatonin derivatives for correction of desynchronization rhythms and also compositions based on these compounds. EFFECT: increased treatment efficiency. 10 cl, 5 dwg, 5 tbl, 9 ex
Authors
Dates
2000-12-10—Published
1994-11-16—Filed